TaiMed Biologics Inc.

TaiMed Biologics Inc.verified

4147.TWO

Price:

$62.8

Market Cap:

$17.16B

TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes various drugs for the treatment and prevention of infectious diseases. The company develops and markets Ibalizumab (TMB-355) Intravenous Infusion, a humanized monoclonal antibody for the treatment of HIV-1 infection. It is also developing TMB-355 Intravenous Push, a humanized monoclonal antibody for the treatment of HIV-1 infection; TMB-355 Intramuscular Injection, a humanized monoclonal antibody intramuscular injection, which is in Phase III clinical trials for treating HIV-1; TMB-365, an anti-CD4 recombinant humanized monoclonal antibody, which completed Phase I clinical trials for treating HIV infec...[Read more]

Industry

Biotechnology

IPO Date

2012-06-20

Stock Exchange

TWO

Ticker

4147.TWO

The Current Ratio as of December 2025 (TTM) for TaiMed Biologics Inc. (4147.TWO) is 18.84

According to TaiMed Biologics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 18.84. This represents a change of -18.56% compared to the average of 23.13 of the last 4 quarters.

TaiMed Biologics Inc. (4147.TWO) Historical Current Ratio (quarterly & annually)

How has 4147.TWO Current Ratio performed in the past?

The mean historical Current Ratio of TaiMed Biologics Inc. over the last ten years is 35.31. The current 18.84 Current Ratio has changed 5.23% with respect to the historical average. Over the past ten years (40 quarters), 4147.TWO's Current Ratio was at its highest in in the September 2016 quarter at 269.52. The Current Ratio was at its lowest in in the March 2020 quarter at 3.36.

Quarterly (TTM)
Annual

Average

35.31

Median

10.52

Minimum

5.74

Maximum

171.81

TaiMed Biologics Inc. (4147.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of TaiMed Biologics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 465.45%

Maximum Annual Current Ratio = 171.81

Minimum Annual Increase = -71.23%

Minimum Annual Current Ratio = 5.74

Quarterly (TTM)
Annual
YearCurrent RatioChange
202425.18322.75%
20235.96-9.24%
20226.56-36.73%
202110.3772.35%
20206.024.87%
20195.74-46.24%
201810.68-71.23%
201737.11-49.62%
201673.67-57.12%
2015171.81465.45%

TaiMed Biologics Inc. (4147.TWO) Average Current Ratio

How has 4147.TWO Current Ratio performed in the past?

The current Current Ratio of TaiMed Biologics Inc. (4147.TWO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

12.57

5-year avg

10.82

10-year avg

35.31

TaiMed Biologics Inc. (4147.TWO) Current Ratio vs. Peers

How is 4147.TWO’s Current Ratio compared to its peers?

TaiMed Biologics Inc.’s Current Ratio is greater than EirGenix Inc. (7.56), greater than Pell Bio-Med Technology Co., Ltd. (3.49), greater than Sunmax Biotechnology Co., Ltd. (3.85), greater than Medigen Vaccine Biologics Corporation (14.12), greater than Tanvex BioPharma, Inc. (2.97), less than Lin BioScience, Inc. (41.18), less than Handa Pharmaceuticals, Inc. (32.44), less than Caliway Biopharmaceuticals Co., Ltd. (114.40), greater than TTY Biopharm Company Limited (1.77), greater than Ever Supreme Bio Technology Co., Ltd (1.69),

Build a custom stock screener for TaiMed Biologics Inc. (4147.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TaiMed Biologics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TaiMed Biologics Inc. (4147.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TaiMed Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is TaiMed Biologics Inc.'s Current Ratio?

How is the Current Ratio calculated for TaiMed Biologics Inc. (4147.TWO)?

What is the highest Current Ratio for TaiMed Biologics Inc. (4147.TWO)?

What is the 3-year average Current Ratio for TaiMed Biologics Inc. (4147.TWO)?

What is the 5-year average Current Ratio for TaiMed Biologics Inc. (4147.TWO)?

How does the current Current Ratio for TaiMed Biologics Inc. (4147.TWO) compare to its historical average?